"Lesser eGFR decline with dulaglutide regardless of weight changes in people with type 2 diabetes and moderate to severe chronic kidney disease (AWARD-7)" by Katherine Tuttle

Selected Works of Katherine R. Tuttle, MD, FASN, FACP, FNKF

Presentation

Lesser eGFR decline with dulaglutide regardless of weight changes in people with type 2 diabetes and moderate to severe chronic kidney disease (AWARD-7)

Congress: European Association for the Study of Diabetes (2018)

Katherine Tuttle, Providence St. Joseph Health
M Lakshmanan
B L Rayner
R S Busch
A G Zimmermann
B Woodward
F T Botros

Disciplines

Endocrinology, Diabetes, and Metabolism and
Nephrology

Publication Date

March, 2018

Citation Information

Katherine Tuttle, M Lakshmanan, B L Rayner, R S Busch, et al.. "Lesser eGFR decline with dulaglutide regardless of weight changes in people with type 2 diabetes and moderate to severe chronic kidney disease (AWARD-7)" Congress: European Association for the Study of Diabetes (2018)
Available at: http://works.bepress.com/katherine-tuttle/147/